Covered recipient · General Payments record
FIORELLA M ZAMBRANO
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2022–2024
$561.30
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.44 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $114.49 | 5 |
| Novo Nordisk AS | $67.90 | 3 |
| Amgen Inc. | $60.31 | 3 |
| Sumitomo Pharma America, Inc. | $28.11 | 1 |
| ABBVIE INC. | $27.92 | 1 |
| Radius Health, Inc. | $27.19 | 1 |
| SANOFI PASTEUR INC. | $19.66 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.92 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108456744 | CMS |
| Amgen Inc. | $23.40 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116221884 | CMS |
| Amgen Inc. | $19.33 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117725130 | CMS |
| Amgen Inc. | $17.58 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117725133 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $17.86 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086293478 | CMS |
| Lilly USA, LLC | $24.38 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135659713 | CMS |
| Lilly USA, LLC | $24.02 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135669822 | CMS |
| Lilly USA, LLC | $15.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135671650 | CMS |
| Lilly USA, LLC | $25.10 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135650673 | CMS |
| Lilly USA, LLC | $25.99 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135659715 | CMS |
| Novo Nordisk Inc | $23.31 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100367381 | CMS |
| Novo Nordisk Inc | $21.96 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100302147 | CMS |
| Novo Nordisk Inc | $22.63 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100393068 | CMS |
| Radius Health, Inc. | $27.19 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090017135 | CMS |
| SANOFI PASTEUR INC. | $19.66 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128753263 | CMS |
| Sumitomo Pharma America, Inc. | $28.11 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149006251 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.